Literature DB >> 9347249

Ontogeny of epidermal growth factor (EGF), EGF receptor (EGFR) and basic fibroblast growth factor (bFGF) mRNA levels in pancreas, liver, kidney, and skeletal muscle of pig.

M Peng1, M F Palin, S Véronneau, D LeBel, G Pelletier.   

Abstract

Epidermal growth factor (EGF), EGF receptor (EGFR), and basic fibroblast growth factor (bFGF) messenger RNA (mRNA) levels were examined by Northern blot analysis in four tissues (pancreas, liver, kidney, and skeletal muscle) of pig from fetal 90 d to postnatal 180 d of age. The present study shows for the first time that EGF mRNA increased with advancing age in the kidney and skeletal muscle of pig. A high level of EGF mRNA was observed in the kidney compared with the liver and skeletal muscle. In the pancreas, high levels of EGF mRNA were found in fetuses and newborns and were low in older pigs. Pancreatic EGFR mRNA level parallelled its EGF mRNA, whereas in the kidney and skeletal muscle, patterns of EGFR mRNA were reversed to their EGF mRNA levels. In the liver, EGFR mRNA was abundant but EGF mRNA was undetected. In the pancreas and skeletal muscle, the highest levels of bFGF mRNA were found in fetuses of 90 d of age and then decreased with advancing age. In the liver and kidney, there were no major changes in bFGF mRNA levels during the examined developmental periods. These results show that EGF, EGFR, and bFGF mRNA levels are developmentally and tissue specifically regulated in pig. In the pancreas, mRNA levels of EGF, EGFR and bFGF were high in fetal and neonatal life and low thereafter. In the kidney and skeletal muscle, EGF mRNA increased with advancing age. EGF may play a role in muscle growth and maintenance in growing pigs during the later stage of development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347249     DOI: 10.1016/s0739-7240(97)00025-8

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  6 in total

1.  Genes with expression levels correlating to drip loss prove association of their polymorphism with water holding capacity of pork.

Authors:  R M Brunner; T Srikanchai; E Murani; K Wimmers; S Ponsuksili
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

2.  The microRNA-30 family is required for vertebrate hepatobiliary development.

Authors:  Nicholas J Hand; Zankhana R Master; Steven F Eauclaire; Daniel E Weinblatt; Randolph P Matthews; Joshua R Friedman
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

3.  Silver nanoparticles administered to chicken affect VEGFA and FGF2 gene expression in breast muscle and heart.

Authors:  Anna Hotowy; Ewa Sawosz; Lane Pineda; Filip Sawosz; Marta Grodzik; André Chwalibog
Journal:  Nanoscale Res Lett       Date:  2012-07-24       Impact factor: 4.703

4.  Gene expression profiling of skeletal myogenesis in human embryonic stem cells reveals a potential cascade of transcription factors regulating stages of myogenesis, including quiescent/activated satellite cell-like gene expression.

Authors:  Michael Shelton; Morten Ritso; Jun Liu; Daniel O'Neil; Avetik Kocharyan; Michael A Rudnicki; William L Stanford; Ilona S Skerjanc; Alexandre Blais
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

5.  Effects of protease-treated royal jelly on muscle strength in elderly nursing home residents: A randomized, double-blind, placebo-controlled, dose-response study.

Authors:  Ge Meng; Honglei Wang; Yinghua Pei; Yanmei Li; Hongmei Wu; Yanqi Song; Qi Guo; Hui Guo; Shinobu Fukushima; Tomoki Tatefuji; Jiazhong Wang; Huanmin Du; Qian Su; Wen Zhang; Suxing Shen; Xiuyang Wang; Renwei Dong; Peipei Han; Tatsuma Okazaki; Ryoichi Nagatomi; Jianhua Wang; Guowei Huang; Zhong Sun; Kun Song; Kaijun Niu
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

6.  Voluntary locomotor activity promotes myogenic growth potential in domestic pigs.

Authors:  Claudia Kalbe; Manuela Zebunke; Dorothea Lösel; Julia Brendle; Steffen Hoy; Birger Puppe
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.